This conflict has intensified due to the proliferation of high-value biologic and peptide therapeutics, specifically Glucagon-like peptide-1 (GLP-1) receptor agonists, which have exposed the friction between patient access mechanisms and commercial exclusivity rights
Reported p-values correspond to the Wilcoxon signed-rank test unless otherwise specified
Temporary skin reactions
Daikyos Crystal Zenith syringe reports sub-1 ppm silicon release, compared with up to 15 ppm for lubricated glass counterparts [3]Daikyo Seiko, Silicon Release Study in Crystal Zenith Syringes, jpharmsci.org
Pre-formulated blends dramatically reduce fluid measurement variables and preparation steps in complex multi-pathway protocols
The honest answer is that the evidence base is still developing, which is true of many treatments that are now standard of care, said Dr Anant Vinjamoori, chief medical officer of Hims